{"id":"NCT02102204","sponsor":"Amgen","briefTitle":"Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis","officialTitle":"A Multicenter Single-arm Extension Study to Describe the Long-term Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-03-25","primaryCompletion":"2016-11-04","completion":"2017-06-26","firstPosted":"2014-04-02","resultsPosted":"2017-11-17","lastUpdate":"2017-11-17"},"enrollment":902,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hyperparathyroidism, Secondary"],"interventions":[{"type":"DRUG","name":"Etelcalcetide","otherNames":["KAI-4169","AMG 416","Parasabiv"]}],"arms":[{"label":"Etelcalcetide","type":"EXPERIMENTAL"}],"summary":"This is a multicenter, single-arm, extension study to characterize the long-term safety and tolerability of etelcalcetide in the treatment of Secondary Hyperparathyroidism (SHPT) in adults with Chronic Kidney Disease (CKD) on hemodialysis.","primaryOutcome":{"measure":"Number of Participants With Adverse Events","timeFrame":"From the date of first dose of etelcalcetide (in the current study) and up to 30 days after the last dose; median duration of treatment was 563 days.","effectByArm":[{"arm":"Etelcalcetide","deltaMin":768,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":228,"countries":["United States","Australia","Austria","Belgium","Canada","Czechia","Denmark","France","Germany","Greece","Hungary","Israel","Italy","Latvia","Lithuania","Netherlands","New Zealand","Poland","Portugal","Russia","Spain","Sweden","Switzerland","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":[],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":436,"n":884},"commonTop":["Blood calcium decreased","Diarrhoea","Hyperphosphataemia","Muscle spasms","Hypertension"]}}